Last reviewed · How we verify
NCT04585399
Increasing MAT Engagement With Financial Incentives
NA trial testing Contingency management in Opioid-use Disorder in 92 participants. Completed in 1 November 2024.
1 November 2024
Quick facts
| Lead sponsor | Rowan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 92 |
| Start date | 27 January 2020 |
| Primary completion | 1 November 2024 |
| Estimated completion | 1 November 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Contingency management
Conditions studied
- Opioid-use Disorder — all drugs for Opioid-use Disorder →
Sponsor
Rowan University
Who can join
18 and older, any sex, with Opioid-use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The increased prevalence of opioid use disorder (OUD) and associated overdoses and adverse events has led to a substantial increase in the number of patients being seen at emergency departments (ED). Thus, the ED may be an ideal location for identifying patients in need of OUD treatment and can serve as the first touch point in the OUD continuum of care to promote medication assisted treatment initiation. Contingency management (CM) is an effective method for promoting treatment initiation and adherence that has not been thoroughly evaluated for this purpose. The primary aim of the current study is to develop and assess the effectiveness, acceptability, and feasibility of a protocol for delivering CM to increase combined buprenorphine + nalaxone (referred to as BUP hereafter) initiation and continuous adherence for OUD in an existing ED "bridge" program (e.g., Bridge plus CM; B+CM) relative to standard care. Secondary objectives include identifying behavioral and neuropsychological correlates to treatment outcomes, including delay discounting, reinforcer demand, and neurological soft signs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04585399
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Contingency management
Trials testing the same drug.
- NCT06931197 — Why Wait? Initiating Contingency Management in Traumatically Injured Patients During Hospitalization · NA · not yet recruiting
- NCT06688539 — E-cigarette Cessation in Adults Who Co-use Cannabis · Phase 4 · recruiting
- NCT06239350 — Young Adult Tobacco/Nicotine and Cannabis Co-use · NA · recruiting
- NCT06134882 — OUD Smartphone Services · NA · active not recruiting
- NCT06564792 — Contingency Management in HIV Care for Both Stimulant Use & ART Adherence · NA · completed
Other recruiting trials for Opioid-use Disorder
Currently open trials in the same condition.
- NCT04783558 — Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk · NA · active not recruiting
- NCT05011266 — Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder · Phase 2, PHASE3 · recruiting
- NCT05039554 — Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment · NA · recruiting
- NCT05033028 — Smartphones for Opiate Addiction Recovery · Phase 3 · recruiting
- NCT04738825 — Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With Pr · NA · recruiting
Other Rowan University trials
Trials by the same sponsor.
- NCT07213388 — Immersive Virtual Reality vs Treadmill Exercise Project · NA · completed
- NCT06235463 — Pedal Pump and Leg Lymphedema · NA · recruiting
- NCT06350604 — Project WHADE: A Partner-Based Physical Activity Program for Women · NA · completed
- NCT07256808 — Medial Tibial Stress Syndrome Prevention · NA · completed
- NCT06651671 — Tissue Changes Following Thoracic Myofascial Release · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04585399 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rowan University
- Last refreshed: 4 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04585399.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing